Covered recipient · General Payments record
RISHI PAUL SINGH
Allopathic & Osteopathic Physicians Ophthalmology
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
Saved only in this browser. No account or alerts.
General Payments · PY2023 · Entire year
$455,984.01
226 records · 0 disputed
“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”
— Centers for Medicare & Medicaid Services, Open Payments
A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.
These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Methodology & Data — sourcing, labeling, and limitations.
Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗
By nature of payment
PY2023 · entire year · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $201,731.50 | 34 |
| Consulting Fee | $183,651.61 | 53 |
| Travel and Lodging | $43,541.24 | 70 |
| Honoraria | $22,100.00 | 6 |
| Food and Beverage | $4,839.46 | 62 |
| Gift | $120.20 | 1 |
By paying entity
PY2023 · entire year · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Apellis Pharmaceuticals, Inc. | $138,897.05 | 70 |
| Regeneron Healthcare Solutions, Inc. | $76,863.87 | 35 |
| Hoffmann-La Roche Limited | $40,168.12 | 16 |
| Coherus Biosciences Inc. | $38,514.55 | 12 |
| EyePoint Pharmaceuticals US, Inc. | $32,460.71 | 14 |
| Genentech USA, Inc. | $28,948.72 | 13 |
| Roche Products Limited | $20,276.43 | 4 |
| Alcon Vision LLC | $17,093.86 | 15 |
| AbbVie Inc. | $15,472.00 | 8 |
| Regeneron Pharmaceuticals, Inc. | $9,777.66 | 9 |
| Ocular Therapeutix, Inc. | $9,379.43 | 5 |
| Alimera Sciences, Inc. | $5,842.68 | 5 |
| Carl Zeiss Meditec, Inc. | $4,704.25 | 4 |
| Genentech, Inc. | $4,317.50 | 2 |
| F. Hoffmann-La Roche AG | $4,279.24 | 2 |
| Kyowa Kirin, Inc. | $3,375.00 | 1 |
| Astellas Pharma US Inc | $3,180.93 | 4 |
| Beaver-Visitec International, Inc. | $1,400.00 | 2 |
| Alcon Research LLC | $651.00 | 1 |
| Bausch & Lomb Americas Inc. | $232.76 | 2 |
| INTUITIVE SURGICAL, INC. | $98.53 | 1 |
| Rayner Intraocular Lenses Limited | $49.72 | 1 |
Page 3 of 5; records 101–150 of 226 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.
IndustryPayments · General Payments
RISHI PAUL SINGH
NPI 1750447660 · CMS profile ID 306129
Allopathic & Osteopathic Physicians / Ophthalmology
BOSTON, MA
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types
Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00
Page 3 of 5; records 101–150 of 226 matching records. This page contains 50 records (maximum 50), not the full filtered export.
Filtered page: https://industrypayments.org/provider/npi-1750447660?year=2023&recipient=provider&page=3#records-h
CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9
Cite these filtered records
The citation includes this program year, filters, data edition, and page of results.
- Plain
- RISHI PAUL SINGH, NPI 1750447660, CMS profile ID 306129. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 5; records 101–150 of 226 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1750447660?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
- APA 7
- IndustryPayments. (2026). RISHI PAUL SINGH, NPI 1750447660, CMS profile ID 306129. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 5; records 101–150 of 226 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1750447660?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
- Bluebook
- RISHI PAUL SINGH, NPI 1750447660, CMS profile ID 306129, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 5; records 101–150 of 226 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1750447660?year=2023&recipient=provider&page=3#records-h.
Centers for Medicare & Medicaid Services, Open Payments
Citation formats are provided for reference; check the requirements of your publication.
Payment records · PY2023
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30
226 matching records · $455,984.01 reported total · 0 disputed
Nature of payment: All payment types
Records imported here (UTC).
CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.
Showing records 101–150 of 226.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Publication flags | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. | $1,080.00 | 07/21/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1000036215 | CMS |
| Alcon Vision LLC | $1,184.31 | 07/14/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1001585203 | CMS |
| Apellis Pharmaceuticals, Inc. | $26.67 | 07/13/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1056332941 | CMS |
| Kyowa Kirin, Inc. | $3,375.00 | 07/11/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1027020057 | CMS |
| Bausch & Lomb Americas Inc. | $122.95 | 07/10/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1037847963 | CMS |
| Coherus Biosciences Inc. | $4,846.50 | 07/06/2023 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1060236783 | CMS |
| Coherus Biosciences Inc. | $834.32 | 07/06/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1060236793 | CMS |
| EyePoint Pharmaceuticals US, Inc. | $6,300.00 | 07/01/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1017492211 | CMS |
| Coherus Biosciences Inc. | $11,847.00 | 06/13/2023 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1060236767 | CMS |
| Coherus Biosciences Inc. | $1,120.07 | 06/13/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1060236769 | CMS |
| Apellis Pharmaceuticals, Inc. | $15,264.00 | 06/12/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1056314555 | CMS |
| Apellis Pharmaceuticals, Inc. | $57.53 | 06/12/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1056366015 | CMS |
| Apellis Pharmaceuticals, Inc. | $1,086.00 | 06/12/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1056371389 | CMS |
| Apellis Pharmaceuticals, Inc. | $26.50 | 06/12/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1056378391 | CMS |
| Alimera Sciences, Inc. | $105.49 | 06/05/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 993543119 | CMS |
| Apellis Pharmaceuticals, Inc. | $58.86 | 06/01/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1056337327 | CMS |
| Coherus Biosciences Inc. | $2,423.25 | 06/01/2023 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1060236765 | CMS |
| Regeneron Healthcare Solutions, Inc. | $2,116.00 | 05/25/2023 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 999448413 | CMS |
| Apellis Pharmaceuticals, Inc. | $59.43 | 05/23/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1056325649 | CMS |
| Apellis Pharmaceuticals, Inc. | $1,086.00 | 05/19/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1056378963 | CMS |
| Regeneron Healthcare Solutions, Inc. | $529.00 | 05/19/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 999448395 | CMS |
| Regeneron Healthcare Solutions, Inc. | $2,645.00 | 05/19/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 999448401 | CMS |
| Regeneron Healthcare Solutions, Inc. | $3,174.00 | 05/19/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 999448407 | CMS |
| Apellis Pharmaceuticals, Inc. | $11,403.00 | 05/17/2023 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1056346361 | CMS |
| Apellis Pharmaceuticals, Inc. | $192.73 | 05/17/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1056351209 | CMS |
| Genentech USA, Inc. | $112.94 | 05/16/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1040522459 | CMS |
| Genentech USA, Inc. | $6,720.00 | 05/16/2023 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1040522467 | CMS |
| Genentech USA, Inc. | $809.56 | 05/16/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1040522475 | CMS |
| Genentech USA, Inc. | $136.33 | 05/16/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1040522483 | CMS |
| Apellis Pharmaceuticals, Inc. | $203.65 | 05/14/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1056335661 | CMS |
| Apellis Pharmaceuticals, Inc. | $490.82 | 05/14/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1056354093 | CMS |
| Apellis Pharmaceuticals, Inc. | $308.97 | 05/13/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1056310169 | CMS |
| Apellis Pharmaceuticals, Inc. | $641.06 | 05/13/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1056318767 | CMS |
| Apellis Pharmaceuticals, Inc. | $262.97 | 05/11/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1056371391 | CMS |
| Apellis Pharmaceuticals, Inc. | $180.00 | 05/11/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1056372208 | CMS |
| Apellis Pharmaceuticals, Inc. | $124.99 | 05/11/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1056378393 | CMS |
| Coherus Biosciences Inc. | $124.97 | 05/10/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1060236775 | CMS |
| Apellis Pharmaceuticals, Inc. | $582.20 | 05/08/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1056312993 | CMS |
| Apellis Pharmaceuticals, Inc. | $125.16 | 05/08/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1056334329 | CMS |
| Apellis Pharmaceuticals, Inc. | $275.45 | 05/08/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1056347547 | CMS |
| Apellis Pharmaceuticals, Inc. | $11,403.00 | 05/08/2023 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1056348807 | CMS |
| Apellis Pharmaceuticals, Inc. | $12.00 | 05/08/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1056373501 | CMS |
| Apellis Pharmaceuticals, Inc. | $574.97 | 05/04/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1056332929 | CMS |
| Apellis Pharmaceuticals, Inc. | $122.61 | 05/04/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1056356525 | CMS |
| Apellis Pharmaceuticals, Inc. | $683.20 | 05/04/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1056378967 | CMS |
| Carl Zeiss Meditec, Inc. | $650.00 | 05/04/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1059458819 | CMS |
| Hoffmann-La Roche Limited | $2,940.00 | 04/27/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1040522669 | CMS |
| Hoffmann-La Roche Limited | $183.44 | 04/27/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1040522680 | CMS |
| Hoffmann-La Roche Limited | $110.06 | 04/27/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1040522687 | CMS |
| Hoffmann-La Roche Limited | $440.25 | 04/27/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1040522693 | CMS |
By program year
All program years on this page · sorted by year
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.
Research Payments
One row per program year and role, newest year first · amounts for the two roles are never added together
| Program year | Role | Amount | Records |
|---|---|---|---|
| PY2025 | Recipient | $25,074.10 | 33 |
| PY2024 | Recipient | $86,441.39 | 39 |
| PY2024 | Principal investigator | $77,458.00 | 2 |
| PY2023 | Recipient | $15,573.65 | 17 |
| PY2022 | Recipient | $10,832.58 | 15 |
| PY2022 | Principal investigator | $87,858.20 | 4 |
| PY2021 | Recipient | $32,639.67 | 19 |
| PY2021 | Principal investigator | $144,278.00 | 12 |
| PY2020 | Recipient | $14,663.11 | 4 |
| PY2020 | Principal investigator | $76,413.70 | 14 |
| PY2019 | Recipient | $13,558.83 | 9 |
| PY2019 | Principal investigator | $401,061.87 | 20 |
Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.
“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”
— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224
Research Payments records · PY2025
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
33 records in PY2025
| Role | Paying entity | Amount | Date | Recipient | Study | Dispute status | Published | Record ID |
|---|---|---|---|---|---|---|---|---|
| Recipient | Regeneron Pharmaceuticals, Inc. | $339.68 | 09/13/2025 | Covered Recipient Physician | EYLEA CLINICAL DEVELOPMENT PROGRAM | No dispute reported | 06/30/2026 | 1184122784 |
| Recipient | Regeneron Pharmaceuticals, Inc. | $339.68 | 09/12/2025 | Covered Recipient Physician | EYLEA CLINICAL DEVELOPMENT PROGRAM | No dispute reported | 06/30/2026 | 1184122780 |
| Recipient | Regeneron Pharmaceuticals, Inc. | $373.65 | 09/12/2025 | Covered Recipient Physician | EYLEA CLINICAL DEVELOPMENT PROGRAM | No dispute reported | 06/30/2026 | 1184122782 |
| Recipient | F. Hoffmann-La Roche AG | $778.13 | 08/29/2025 | Covered Recipient Physician | 12-Month Real-World Clinical and Anatomical Outcomes With Faricimab in Patients With Diabetic Macular Edema: The FARETINA-DME Study | No dispute reported | 06/30/2026 | 1211538519 |
| Recipient | F. Hoffmann-La Roche AG | $778.13 | 08/29/2025 | Covered Recipient Physician | 12-Month Real-World Clinical and Anatomical Outcomes With Faricimab in Patients With Neovascular Age-Related Macular Degeneration: FARETINA-AMD | No dispute reported | 06/30/2026 | 1211538523 |
| Recipient | Regeneron Pharmaceuticals, Inc. | $340.75 | 07/31/2025 | Covered Recipient Physician | EYLEA CLINICAL DEVELOPMENT PROGRAM | No dispute reported | 06/30/2026 | 1184122778 |
| Recipient | Regeneron Pharmaceuticals, Inc. | $340.75 | 07/29/2025 | Covered Recipient Physician | EYLEA CLINICAL DEVELOPMENT PROGRAM | No dispute reported | 06/30/2026 | 1184122772 |
| Recipient | Regeneron Pharmaceuticals, Inc. | $340.75 | 07/29/2025 | Covered Recipient Physician | EYLEA CLINICAL DEVELOPMENT PROGRAM | No dispute reported | 06/30/2026 | 1184122774 |
| Recipient | Regeneron Pharmaceuticals, Inc. | $340.75 | 07/29/2025 | Covered Recipient Physician | EYLEA CLINICAL DEVELOPMENT PROGRAM | No dispute reported | 06/30/2026 | 1184122776 |
| Recipient | Regeneron Pharmaceuticals, Inc. | $3,179.07 | 07/02/2025 | Covered Recipient Physician | EYLEA CLINICAL DEVELOPMENT PROGRAM | No dispute reported | 06/30/2026 | 1184122770 |
| Recipient | F. Hoffmann-La Roche AG | $1,199.63 | 05/06/2025 | Covered Recipient Physician | Two-year real-world clinical outcomes in patients with neovascular age-related macular degeneration treated with faricimab in the US: The FARETINA-nAMD study | No dispute reported | 06/30/2026 | 1211538527 |
| Recipient | Regeneron Pharmaceuticals, Inc. | $711.26 | 05/06/2025 | Covered Recipient Physician | EYLEA CLINICAL DEVELOPMENT PROGRAM | No dispute reported | 06/30/2026 | 1184122766 |
| Recipient | Regeneron Pharmaceuticals, Inc. | $711.26 | 05/06/2025 | Covered Recipient Physician | EYLEA CLINICAL DEVELOPMENT PROGRAM | No dispute reported | 06/30/2026 | 1184122768 |
| Recipient | F. Hoffmann-La Roche AG | $1,863.75 | 05/05/2025 | Covered Recipient Physician | Two-year real-world clinical outcomes in patients with diabetic macular edema treated with faricimab in the US: The FARETINA-DME study | No dispute reported | 06/30/2026 | 1211538532 |
| Recipient | Regeneron Pharmaceuticals, Inc. | $711.26 | 05/05/2025 | Covered Recipient Physician | EYLEA CLINICAL DEVELOPMENT PROGRAM | No dispute reported | 06/30/2026 | 1184122762 |
| Recipient | Regeneron Pharmaceuticals, Inc. | $711.26 | 05/05/2025 | Covered Recipient Physician | EYLEA CLINICAL DEVELOPMENT PROGRAM | No dispute reported | 06/30/2026 | 1184122764 |
| Recipient | Regeneron Pharmaceuticals, Inc. | $52.89 | 05/02/2025 | Covered Recipient Physician | EYLEA CLINICAL DEVELOPMENT PROGRAM | No dispute reported | 06/30/2026 | 1184122756 |
| Recipient | Regeneron Pharmaceuticals, Inc. | $48.96 | 05/02/2025 | Covered Recipient Physician | EYLEA CLINICAL DEVELOPMENT PROGRAM | No dispute reported | 06/30/2026 | 1184122758 |
| Recipient | Regeneron Pharmaceuticals, Inc. | $53.86 | 05/02/2025 | Covered Recipient Physician | EYLEA CLINICAL DEVELOPMENT PROGRAM | No dispute reported | 06/30/2026 | 1184122760 |
| Recipient | Regeneron Pharmaceuticals, Inc. | $5,492.60 | 04/26/2025 | Covered Recipient Physician | EYLEA CLINICAL DEVELOPMENT PROGRAM | No dispute reported | 06/30/2026 | 1184122754 |
| Recipient | Regeneron Pharmaceuticals, Inc. | $44.88 | 04/16/2025 | Covered Recipient Physician | EYLEA CLINICAL DEVELOPMENT PROGRAM | No dispute reported | 06/30/2026 | 1184122745 |
| Recipient | Regeneron Pharmaceuticals, Inc. | $44.88 | 04/16/2025 | Covered Recipient Physician | EYLEA CLINICAL DEVELOPMENT PROGRAM | No dispute reported | 06/30/2026 | 1184122747 |
| Recipient | Regeneron Pharmaceuticals, Inc. | $44.88 | 04/16/2025 | Covered Recipient Physician | EYLEA CLINICAL DEVELOPMENT PROGRAM | No dispute reported | 06/30/2026 | 1184122750 |
| Recipient | Regeneron Pharmaceuticals, Inc. | $44.88 | 04/16/2025 | Covered Recipient Physician | EYLEA CLINICAL DEVELOPMENT PROGRAM | No dispute reported | 06/30/2026 | 1184122752 |
| Recipient | F. Hoffmann-La Roche AG | $778.13 | 03/31/2025 | Covered Recipient Physician | 12-Month Real-World Clinical and Anatomical Outcomes With Faricimab in Patients With Diabetic Macular Edema: The FARETINA-DME Study | No dispute reported | 06/30/2026 | 1211538537 |
| Recipient | F. Hoffmann-La Roche AG | $1,370.25 | 03/31/2025 | Covered Recipient Physician | Real-World Clinical Outcomes Update in Patients With Neovascular Age-Related Macular Degeneration in the US: The FARETINA-AMD Study | No dispute reported | 06/30/2026 | 1211538543 |
| Recipient | F. Hoffmann-La Roche AG | $1,205.75 | 03/31/2025 | Covered Recipient Physician | 2-Year Real-World Clinical and Anatomical Outcomes in Patients With Neovascular Age-Related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME) Treated With Faricimab in the United States: The FARETINA Study | No dispute reported | 06/30/2026 | 1211538547 |
| Recipient | F. Hoffmann-La Roche AG | $1,370.25 | 03/31/2025 | Covered Recipient Physician | Real-World Clinical Outcomes Update in Patients With Diabetic Macular Edema Treated With Faricimab in the US: The FARETINA-DME Study | No dispute reported | 06/30/2026 | 1211538552 |
| Recipient | F. Hoffmann-La Roche AG | $778.13 | 03/31/2025 | Covered Recipient Physician | 12-Month Real-World Clinical and Anatomical Outcomes With Faricimab in Patients With Neovascular Age-Related Macular Degeneration: FARETINA-AMD | No dispute reported | 06/30/2026 | 1211538556 |
| Recipient | Regeneron Pharmaceuticals, Inc. | $171.00 | 01/14/2025 | Covered Recipient Physician | EYLEA CLINICAL DEVELOPMENT PROGRAM | No dispute reported | 06/30/2026 | 1184122737 |
| Recipient | Regeneron Pharmaceuticals, Inc. | $171.00 | 01/14/2025 | Covered Recipient Physician | EYLEA CLINICAL DEVELOPMENT PROGRAM | No dispute reported | 06/30/2026 | 1184122739 |
| Recipient | Regeneron Pharmaceuticals, Inc. | $171.00 | 01/14/2025 | Covered Recipient Physician | EYLEA CLINICAL DEVELOPMENT PROGRAM | No dispute reported | 06/30/2026 | 1184122741 |
| Recipient | Regeneron Pharmaceuticals, Inc. | $171.00 | 01/14/2025 | Covered Recipient Physician | EYLEA CLINICAL DEVELOPMENT PROGRAM | No dispute reported | 06/30/2026 | 1184122743 |